# Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET

> **NCT01699828** · PHASE1,PHASE2 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 6 (actual)

## Conditions studied

- Smoking Cessation
- Tobacco Use Cessation

## Interventions

- **DRUG:** Buspirone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01699828
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699828, "Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01699828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*